Tissue Donors

• 

  Subject Areas on Research

  • 'Chimeric' grafts assembled from multiple allodisparate donors enjoy enhanced transplant survival. 
  • A Heterotopic Xenograft Model of Human Airways for Investigating Fibrosis in Asthma. 
  • A Porcine Heterotopic Heart Transplantation Protocol for Delivery of Therapeutics to a Cardiac Allograft. 
  • A UNOS perspective on donor liver allocation. United Network for Organ Sharing. 
  • A change of heart: Preliminary results of the US 2018 adult heart allocation revision. 
  • A comparison of donor-specific and random transfusions in living-related renal transplantation and their effect on steroid withdrawal. 
  • A cost-minimization analysis of tissue-engineered constructs for corneal endothelial transplantation. 
  • A device to facilitate limbal stem cell procurement from eye bank donor tissue for keratolimbal allograft procedures. 
  • A flow cytometric crossmatch test using endothelial precursor cells isolated from peripheral blood. 
  • A gift of life: ethical and practical problems with conditional and directed donation. 
  • A meta-analysis of complications following deceased donor liver transplant. 
  • A pilot study in sub-SMAS face transplantation: defining donor compatibility and assessing outcomes in a cadaver model. 
  • A prospective multicenter pilot study of HIV-positive deceased donor to HIV-positive recipient kidney transplantation: HOPE in action. 
  • A report of the first pediatric heart transplant following donation after circulatory death in the United States using ex-vivo perfusion. 
  • A technique for management of multiple renal arteries after laparoscopic donor nephrectomy. 
  • A three-tier system for evaluation of organ procurement organizations' willingness to pursue and utilize nonideal donor lungs. 
  • A trade secret model for genomic biobanking. 
  • APOL1 Genotype and Kidney Transplantation Outcomes From Deceased African American Donors. 
  • APOL1: a case in point for replacing race with genetics. 
  • Acute cellular rejection and humoral sensitization in lung transplant recipients. 
  • Acute graft-versus-host disease: analysis of risk factors after allogeneic marrow transplantation and prophylaxis with cyclosporine and methotrexate. 
  • Addressing sex-based disparities in solid organ transplantation in the United States - a conference report. 
  • Advances in pancreas transplantation: the University of Wisconsin experience. 
  • Aggressive pursuit and utilization of non-ideal donor lungs does not compromise post-lung transplant survival. 
  • Agree on much, except it is time for change. 
  • Air bubble-associated endothelial trauma in descemet stripping automated endothelial keratoplasty. 
  • Alemtuzumab induction and triple maintenance immunotherapy in kidney transplantation from donors after cardiac death. 
  • Alimentary tract complications after renal transplantation. 
  • American Society of Transplant Surgeons recommendations on best practices in donation after circulatory death organ procurement. 
  • Amino acid substitution at peptide-binding pockets of HLA class I molecules increases risk of severe acute GVHD and mortality. 
  • Anaesthetic management of the brain dead for organ donation. 
  • Analysis of primate renal allografts after T-cell depletion with anti-CD3-CRM9. 
  • Another Step Toward Becoming a Transplant Community. 
  • Antibody depletion strategy for the treatment of suspected antibody-mediated rejection in lung transplant recipients: Does it work? 
  • Antibody-mediated rejection of the lung: A consensus report of the International Society for Heart and Lung Transplantation. 
  • Apolipoprotein L1 gene variants in deceased organ donors are associated with renal allograft failure. 
  • Apoptotic Donor Cells in Transplantation. 
  • Applying rigor and reproducibility standards to assay donor-derived cell-free DNA as a non-invasive method for detection of acute rejection and graft injury after heart transplantation. 
  • Are we ready to utilize non-heart-beating donors for clinical allotransplantation in China? 
  • Assessment and management of donor pain following marrow harvest for allogeneic bone marrow transplantation. 
  • Assessment of cadaveric organ viability during pulsatile perfusion using infrared imaging. 
  • Assessment of cardiac allograft systolic function by global longitudinal strain: From donor to recipient. 
  • Assessment of living renal donors with spiral CT. 
  • Association of Inherited Chromosomally Integrated Human Herpesvirus 6 with Neurologic Symptoms and Management after Allogeneic Hematopoietic Cell Transplantation. 
  • Banff Lung Report: Current knowledge and future research perspectives for diagnosis and treatment of pulmonary antibody-mediated rejection (AMR). 
  • Banff study of pathologic changes in lung allograft biopsy specimens with donor-specific antibodies. 
  • Bayesian probit regression model for the diagnosis of pulmonary fibrosis: proof-of-principle. 
  • Beta-adrenergic receptor polymorphisms and cardiac graft function in potential organ donors. 
  • Biliary stricture secondary to donor B-cell lymphoma after orthotopic liver transplantation. 
  • Biomechanical strain as a trigger for pore formation in Schlemm's canal endothelial cells. 
  • Bone marrow transplantation in the perinatal period. 
  • Bone marrow transplants from unrelated donors for patients with chronic myeloid leukemia. 
  • Brain death alters cardiopulmonary hemodynamics and impairs right ventricular power reserve against an elevation of pulmonary vascular resistance. 
  • Brain death significantly reduces isolated pancreatic islet yields and functionality in vitro and in vivo after transplantation in rats. 
  • Brief report: lymphoma of donor origin occurring in the porta hepatis of a transplanted liver. 
  • Buyer beware: The risks of donor-derived vaccine-induced thrombosis and thrombocytopenia. 
  • C4 article: Implications of COVID-19 in transplantation. 
  • C4: An experiment in academic dialogue. 
  • CD154 blockade, sirolimus, and donor-specific transfusion prevents renal allograft rejection in cynomolgus monkeys despite homeostatic T-cell activation. 
  • CD68/CD31 immunohistochemistry double stain demonstrates increased accuracy in diagnosing pathologic antibody-mediated rejection in cardiac transplant patients. 
  • CXCR1-mediated neutrophil degranulation and fungal killing promote Candida clearance and host survival. 
  • Cadaver renal transplantation ignoring peak-reactive sera in patients with markedly decreasing pretransplant sensitization. 
  • Cardiac cell therapy in vitro: reproducible assays for comparing the efficacy of different donor cells. 
  • Cardiac dysfunction following brain death in children: prevalence, normalization, and transplantation. 
  • Cardiothoracic Transplant Recipient Mycoplasma hominis: An Uncommon Infection with Probable Donor Transmission. 
  • Cardiovascular mechanism of donor brain death and heart recipient survival. 
  • Casting a smaller net into a bigger donor pool: A single center's experience with the new kidney allocation system. 
  • Cellular Therapies in Solid Organ Allotransplantation: Promise and Pitfalls. 
  • Cellular basis for bimatoprost effects on human conventional outflow. 
  • Cellular immunology markers postransplantation predictive of long-term graft outcome. 
  • Changes in Use of Left Ventricular Assist Devices as Bridge to Transplantation With New Heart Allocation Policy. 
  • Changing spectrum of pediatric renal transplantation. 
  • Characterization of Corneal Donor Tissue Lesions by Anterior Segment Optical Coherence Tomography Compared With Eye Bank Technician Slit-Lamp Examination. 
  • Chronic allograft nephropathy uniformly affects recipients of cadaveric, nonidentical living-related, and living-unrelated grafts. 
  • Circulating mitochondria in organ donors promote allograft rejection. 
  • Circumferential tensile stiffness of glaucomatous trabecular meshwork. 
  • Clinical Risk Factors and Prognostic Model for Primary Graft Dysfunction after Lung Transplantation in Patients with Pulmonary Hypertension. 
  • Clinical course and origin of epithelium in cases of epithelial downgrowth after Descemet stripping automated endothelial keratoplasty. 
  • Clinical recommendations for posttransplant assessment of anti-HLA (Human Leukocyte Antigen) donor-specific antibodies: A Sensitization in Transplantation: Assessment of Risk consensus document. 
  • Clinical risks and healthcare utilization of hematopoietic cell transplantation for sickle cell disease in the USA using merged databases. 
  • Clinicopathologic studies of eyes that were obtained postmortem from four patients who were enrolled in the submacular surgery trials: SST Report No. 16. 
  • Coccidioidomycosis Transmission Through Organ Transplantation: A Report of the OPTN Ad Hoc Disease Transmission Advisory Committee. 
  • Commentary: A longer agonal period in lungs donated after circulatory determination of death is a gamble worth taking. 
  • Commentary: An innovative strategy for expanding the donor pool. 
  • Commentary: Bruised and battered, but not broken-use of lung allografts from donors with chest trauma. 
  • Commentary: Innovation…or disruption and the delayed acknowledgement of a new reality. 
  • Common gamma chain cytokines promote rapid in vitro expansion of allo-specific human CD8+ suppressor T cells. 
  • Communication gaps associated with donor-derived infections. 
  • Communication gaps for solid organ transplant-transmitted infections among infectious disease physicians: an Emerging Infections Network survey. 
  • Complement-targeting therapeutics for ischemia-reperfusion injury in transplantation and the potential for ex vivo delivery. 
  • Composite tissue transplantation: a rapidly advancing field. 
  • Compulsory Organ Retrieval: Morally, But Not Socially, Justified. 
  • Concentration-related effects of nitric oxide and endothelin-1 on human trabecular meshwork cell contractility. 
  • Consensus conference report: maximizing use of organs recovered from the cadaver donor: cardiac recommendations, March 28-29, 2001, Crystal City, Va. 
  • Consensus recommendations for trabecular meshwork cell isolation, characterization and culture. 
  • Consent for organ donation after circulatory death at U.S. transplant centers. 
  • Contractarianism and the "trolley" problem. 
  • Controlled non-heart-beating donors: a potential source of extrarenal organs. 
  • Cord blood banking for potential future transplantation: subject review. American Academy of Pediatrics. Work Group on Cord Blood Banking. 
  • Cornea donation laws in the United States. 
  • Cost Minimization Analysis of Precut Cornea Grafts in Descemet Stripping Automated Endothelial Keratoplasty. 
  • Critical care aspects of lung transplantation. 
  • Critically appraising the 2018 United Network for Organ Sharing donor allocation policy: adding life boats or rearranging the deck chairs? 
  • Cryptococcus transmission through solid organ transplantation in the United States: A report from the Ad Hoc Disease Transmission Advisory Committee. 
  • Current concepts and controversies in lung transplantation. 
  • Current opinions in organ allocation. 
  • Current status of bone marrow transplantation. 
  • Custom, Contract, and Kidney Exchange 
  • DNA typing for HLA-A and HLA-B identifies disparities between patients and unrelated donors matched by HLA-A and HLA-B serology and HLA-DRB1. 
  • De novo donor-specific HLA antibodies are associated with early and high-grade bronchiolitis obliterans syndrome and death after lung transplantation. 
  • Deceased donor multidrug resistance protein 1 and caveolin 1 gene variants may influence allograft survival in kidney transplantation. 
  • Deceased-Donor Apolipoprotein L1 Renal-Risk Variants Have Minimal Effects on Liver Transplant Outcomes. 
  • Decline of Increased Risk Donor Offers on Waitlist Survival in Heart Transplantation. 
  • Declined organ offers in liver transplantation: careful timing or missed opportunity? 
  • Delay of CMV infection in high-risk CMV mismatch lung transplant recipients due to prophylaxis with oral ganciclovir. 
  • Descemet-stripping automated endothelial keratoplasty (DSAEK): effect of nontoxic gentian violet marking pen on DSAEK donor tissue viability by using vital dye assay. 
  • Descemet-stripping automated endothelial keratoplasty with a donor tissue injector. 
  • Descemet-stripping automated endothelial keratoplasty: effect of anterior lamellar corneal tissue-on/-off storage condition on Descemet-stripping automated endothelial keratoplasty donor tissue. 
  • Descemet-stripping automated endothelial keratoplasty: effect of inserting forceps on DSAEK donor tissue viability by using an in vitro delivery model and vital dye assay. 
  • Determinants of willingness to donate living related and cadaveric organs: identifying opportunities for intervention. 
  • Developing SDOCT to assess donor human eyes prior to tissue sectioning for research. 
  • Development of a quantitative donor risk index to predict short-term mortality in orthotopic heart transplantation. 
  • Differential effects of donor-specific alloantibody. 
  • Differential inflammatory responses of the native left and right ventricle associated with donor heart preservation. 
  • Differential response and withdrawal profile of glucocorticoid-treated human trabecular meshwork cells. 
  • Direct-Acting Antivirals and Organ Transplantation: Is There Anything We Can't Do? 
  • Dislocation of the donor graft to the posterior segment in descemet stripping automated endothelial keratoplasty. 
  • Disposition of sperm donors with resultant abnormal pregnancies. 
  • Distributing scarce livers: the moral reasoning of the general public. 
  • Do We Need Full Donor Chimerism? How Alloreactive Cell Therapies without Substantial Engraftment Might Treat Hematologic Cancers. 
  • Do donors matter? Short telomeres and survival after lung transplant. 
  • Do incentives matter? Providing benefits to families of organ donors. 
  • Dominant late-onset retinal degeneration with regional variation of sub-retinal pigment epithelium deposits, retinal function, and photoreceptor degeneration. 
  • Domino liver transplantation in maple syrup urine disease: a case report and review of the literature. 
  • Donation After Circulatory Death in Heart Transplantation: History, Outcomes, Clinical Challenges, and Opportunities to Expand the Donor Pool. 
  • Donation after cardiac death: the University of Wisconsin experience with liver transplantation. 
  • Donation after cardiac death: the University of Wisconsin experience. 
  • Donation after cardiac death: the university of wisconsin experience with renal transplantation. 
  • Donor and recipient age matching in heart transplantation: analysis of the UNOS Registry. 
  • Donor cell leukemia in umbilical cord blood transplant patients: a case study and literature review highlighting the importance of molecular engraftment analysis. 
  • Donor cell-derived leukemias/myelodysplastic neoplasms in allogeneic hematopoietic stem cell transplant recipients: a clinicopathologic study of 10 cases and a comprehensive review of the literature. 
  • Donor derived hepatitis B virus infection: Analysis of the Organ Procurement & Transplantation Network/United Network for Organ Sharing Ad Hoc Disease Transmission Advisory Committee. 
  • Donor designation: racial and ethnic differences in US nondesignators' preferred methods for disclosing intent to donate organs. 
  • Donor evaluation in the era of HIV-positive organ transplantation: The importance of the infectious diseases specialist. 
  • Donor factors affecting outcome after pancreas transplantation. 
  • Donor factors associated with epithelial defects after penetrating keratoplasty. 
  • Donor factors predicting recipient survival after liver retransplantation: the retransplant donor risk index. 
  • Donor fraction cell-free DNA and rejection in adult and pediatric heart transplantation. 
  • Donor genomics influence graft events: the effect of donor polymorphisms on acute rejection and chronic allograft nephropathy. 
  • Donor hepatic function: a factor in postreperfusion syndrome. 
  • Donor immune reconstitution after liver-small bowel transplantation for multiple intestinal atresia with immunodeficiency. 
  • Donor predictors of allograft use and recipient outcomes after heart transplantation. 
  • Donor risk index predicts graft failure reliably but not post-transplant infections. 
  • Donor specific bone marrow cells suppress lymphocyte reactivity to donor antigens and differentially modulate TH1 and TH2 cytokine gene expression in the responder cell population. 
  • Donor-Derived Mycoplasma hominis and an Apparent Cluster of M. hominis Cases in Solid Organ Transplant Recipients. 
  • Donor-Derived Neuroendocrine Carcinoma Transmission to Two Kidney Transplant Recipients Demonstrated by Short Tandem Repeat Analysis: A Case Report. 
  • Donor-Recipient Height Mismatch Is Associated With Decreased Survival in Pediatric-to-Adult Liver Transplant Recipients. 
  • Donor-conceived children: the view ahead. 
  • Donor-derived hepatitis C in the era of increasing intravenous drug use: A report of the Disease Transmission Advisory Committee. 
  • Donor-derived hepatitis C transmission from NAT negative donors-Still an unexpected event! 
  • Donor-derived infections in solid organ transplant patients: toward a holistic approach. 
  • Donor-derived infections: Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice. 
  • Donor-derived transmission events in 2013: a report of the Organ Procurement Transplant Network Ad Hoc Disease Transmission Advisory Committee. 
  • Donor-derived tuberculosis among solid organ transplant recipients in the United States-2008 to 2018. 
  • Donor-directed MHC class I antibody is preferentially cleared from sensitized recipients of combined liver/kidney transplants. 
  • Donor-origin cancer in renal transplant recipients from deceased donors: worth gambling? 
  • Donor-specific CD8+ Foxp3+ T cells protect skin allografts and facilitate induction of conventional CD4+ Foxp3+ regulatory T cells. 
  • Donor-specific bone marrow cells suppress lymphocyte reactivity to donor antigens and differentially modulate TH1 and TH2 cytokine gene expression in the responder cell population. 
  • Double genetic modification of adenovirus fiber with RGD polylysine motifs significantly enhances gene transfer to isolated human pancreatic islets. 
  • Double renal allografts successfully increase utilization of kidneys from older donors within a single organ procurement organization. 
  • Dual Procurement of Lung and Heart Allografts Does Not Negatively Affect Lung Transplant Outcomes. 
  • EXPANDing the Donor Pool: Quantifying the Potential Impact of a Portable Organ-Care System for Expanded Criteria Heart Donation. 
  • Early experience with the use of hepatitis C antibody-positive, nucleic acid testing-negative donors in lung transplantation. 
  • Ebola virus disease: implications for solid organ transplantation. 
  • Ectopic pregnancy rate increases with the number of retrieved oocytes in autologous in vitro fertilization with non-tubal infertility but not donor/recipient cycles: an analysis of 109,140 clinical pregnancies from the Society for Assisted Reproductive Technology registry. 
  • Editorial position on publishing articles on human organ transplantation. 
  • Effect of HLA-matching recipients to donor noninherited maternal antigens on outcomes after mismatched umbilical cord blood transplantation for hematologic malignancy. 
  • Effect of cornea donor graft thickness on the outcome of Descemet stripping automated endothelial keratoplasty surgery. 
  • Effect of donor age on survival of liver transplant recipients with hepatitis C virus infection. 
  • Effect of donor factors on early graft survival in adult cadaveric renal transplantation. 
  • Effect of surrogate tolerogenesis on the vascular rejection of pig heart xenografts. 
  • Effects of donor age on proteasome activity and senescence in trabecular meshwork cells. 
  • Electrocardiographic characteristics of potential organ donors and associations with cardiac allograft use. 
  • Elevated Cardiac Troponin I in Preservation Solution Is Associated With Primary Graft Dysfunction. 
  • Elevated Donor Hemoglobin A1C Impairs Kidney Graft Survival From Deceased Donors With Diabetes Mellitus: A National Analysis. 
  • Elevated HbA1c in donor organs from patients without a diagnosis of diabetes portends worse liver allograft survival. 
  • Elevated Risk of Split-Liver grafts in adult liver Transplantation: Statistical Artifact or Nature of the Beast? 
  • Elevated donor hemoglobin A1c does not impair early survival in cardiac transplant recipients. 
  • Elevated levels of RhoA in the optic nerve head of human eyes with glaucoma. 
  • Endemic Fungal Infection Recommendations for Solid-Organ Transplant Recipients and Donors. 
  • Endocrine changes and haemodynamic stability after brain death. 
  • Endomyocardial Biopsy Characterization of Heart Failure With Preserved Ejection Fraction and Prevalence of Cardiac Amyloidosis. 
  • Endothelial graft failure after contralateral autologous corneal transplantation. 
  • Enhanced isolated pancreatic islet recovery and functionality in rats by 17beta-estradiol treatment of brain death donors. 
  • Ethical considerations of using a single minor donor for three bone marrow harvests for three HLA-matched siblings with primary immunodeficiency. 
  • Evaluation of Racial and Ethnic Disparities in Cardiac Transplantation. 
  • Evaluation of an Abnormal Liver Panel After Liver Transplantation. 
  • Ex Vivo Delivery of Viral Vectors by Organ Perfusion for Cardiac Transplantation Gene Therapy. 
  • Ex Vivo Gene Delivery to Porcine Cardiac Allografts Using a Myocardial-Enhanced Adeno-Associated Viral Vector. 
  • Ex-vivo liver perfusion for organ preservation: Recent advances in the field. 
  • Expanding donor availability in lung transplantation: A case report of 5000 miles traveled. 
  • Expanding the Donor Pool With Normothermic Ex Vivo Liver Perfusion: The Future Is Now. 
  • Expanding the use of hepatitis C-viremic kidney donors. 
  • Experience with a novel efalizumab-based immunosuppressive regimen to facilitate single donor islet cell transplantation. 
  • Experience with reduced-size liver transplantation in infants and children. 
  • Expression of heat shock proteins in myocardium of patients with atrial fibrillation. 
  • Extended post-ex vivo lung perfusion cold preservation predicts primary graft dysfunction and mortality: Results from a multicentric study. 
  • Extending the boundaries of acceptable organ donors: a means of expanding the donor pool for liver transplantation. 
  • Eye Care Professionals' Perspectives on Eye Donation and an Eye Donation Registry for Research: A Single-Institution, Cross-Sectional Study. 
  • Factors which have a significant effect on the survival of human skin grafts. 
  • Fate of four cadaveric donor renal allografts with mesangial IgA deposits. 
  • Feasibility of low-dose interleukin-2 therapy following T-cell-depleted nonmyeloablative allogeneic hematopoietic stem cell transplantation from HLA-matched or -mismatched family member donors. 
  • Female Sex Is Associated with Improved Long-Term Survival Following Allogeneic Hematopoietic Stem Cell Transplantation. 
  • Fibrosing cholestatic hepatitis after kidney transplantation from HCV-viremic donors to HCV-negative recipients: A unique complication in the DAA era. 
  • Foreigners traveling to the U.S. for transplantation may adversely affect organ donation: a national survey. 
  • Free vascularized fibular transfer for femoral head osteonecrosis: donor and graft site morbidity. 
  • Generation of high-affinity human antibodies by combining donor-derived and synthetic complementarity-determining-region diversity. 
  • Genetic determinants of renal transplant outcome: where do we stand? 
  • Going the distance for procurement of donation after circulatory death livers for transplantation-Does reimbursement reflect reality? 
  • Graft donor selection based upon single locus (haplotype) analysis within families. 
  • Graft loss due to recurrent focal segmental glomerulosclerosis in renal transplant recipients in the United States. 
  • Graft-versus-host disease and survival in patients with aplastic anemia treated by marrow grafts from HLA-identical siblings. Beneficial effect of a protective environment. 
  • Graft-versus-host reactions: anti-leukemia effects of donor T cells. 
  • Granulocyte colony-stimulating factor after allogeneic bone marrow transplantation. 
  • HLA-C and liver transplant outcomes: interpreting the facts. 
  • HOPE in action: A prospective multicenter pilot study of liver transplantation from donors with HIV to recipients with HIV. 
  • Half-life analysis of pancreas and kidney transplants. 
  • Hand transplantation in the United States: experience with 3 patients. 
  • Health-related quality of life in reduced-intensity hematopoietic cell transplantation based on donor availability in patients aged 50-75 with advanced myelodysplastic syndrome: BMT CTN 1102. 
  • Heart Transplantation Survival and the Use of Traumatically Brain-Injured Donors: UNOS Registry Propensity-Matched Analysis. 
  • Heart Transplantation: An In-Depth Survival Analysis. 
  • Hematopoietic Stem Cell Transplantation in ADA2 Deficiency: Early Restoration of ADA2 Enzyme Activity and Disease Relapse upon Drop of Donor Chimerism. 
  • Hematopoietic stem cell transplantation. 
  • Hemorrhagic cystitis after allogeneic bone marrow transplantation in children: clinical characteristics and outcome. 
  • Hepatitis B core antibody positive donors as a safe and effective therapeutic option to increase available organs for lung transplantation. 
  • Hepatitis C disease severity in living versus deceased donor liver transplant recipients: an extended observation study. 
  • Hepatocellular carcinoma recurrence and death following living and deceased donor liver transplantation. 
  • High clinical suspicion of donor-derived disease leads to timely recognition and early intervention to treat solid organ transplant-transmitted lymphocytic choriomeningitis virus. 
  • Higher Risks of Toxicity and Incomplete Recovery in 13- to 17-Year-Old Females after Marrow Donation: RDSafe Peds Results. 
  • Horseshoe kidney transplantation. 
  • Hospitalization rates before and after adult-to-adult living donor or deceased donor liver transplantation. 
  • Human CD4+CD25low adaptive T regulatory cells suppress delayed-type hypersensitivity during transplant tolerance. 
  • Human Leukocyte Antigen Sensitization in Solid Organ Transplantation: A Primer on Terminology, Testing, and Clinical Significance for the Apheresis Practitioner. 
  • IFI16-STING-NF-κB signaling controls exogenous mitochondrion-induced endothelial activation. 
  • IgG4 donor-specific HLA antibody profile is associated with subclinical rejection in stable pediatric liver recipients. 
  • Immune reconstitution and survival of 100 SCID patients post-hematopoietic cell transplant: a PIDTC natural history study. 
  • Immunity of patients surviving 20 to 30 years after allogeneic or syngeneic bone marrow transplantation. 
  • Impact of ABO compatibility on outcomes after heart transplantation in a national cohort during the past decade. 
  • Impact of EGF, IL28B, and PNPLA3 polymorphisms on the outcome of allograft hepatitis C: a multicenter study. 
  • Impact of bone marrow transplantation for symptomatic sickle cell disease: an interim report. Multicenter investigation of bone marrow transplantation for sickle cell disease. 
  • Impact of donor and recipient hepatitis C status in lung transplantation. 
  • Impact of donor cardiac arrest on heart transplantation. 
  • Impact of donor factors and preservation on function and survival after liver transplantation. 
  • Impact of donor-to-recipient weight ratio on survival after heart transplantation: analysis of the United Network for Organ Sharing Database. 
  • Impact of improving immunosuppressive treatment on outcome in cadaveric kidney transplantation. 
  • Impact of the 2018 UNOS Heart Transplant Policy Changes on Patient Outcomes. 
  • Impact of the model for end-stage liver disease allocation policy on the use of high-risk organs for liver transplantation. 
  • Implementation of vascularized composite allografts in the United States: recommendations from the ASTS VCA Ad Hoc Committee and the Executive Committee. 
  • Implications of blood group on lung transplantation rates: A propensity-matched registry analysis. 
  • Improved Outcomes in Severe Primary Graft Dysfunction After Heart Transplantation Following Donation After Circulatory Death Compared With Donation After Brain Death. 
  • Improved contemporary outcomes of liver transplantation for pediatric hepatoblastoma and hepatocellular carcinoma. 
  • Improved strategy for mononuclear cell collection for donor lymphocyte infusions. 
  • Improvement in Liver Transplant Outcomes From Older Donors: A US National Analysis. 
  • In vitro pilot analysis of uniformity, circularity, and concentricity of DSAEK donor endothelial grafts prepared by a microkeratome. 
  • Incidence and impact of primary graft dysfunction in adult heart transplant recipients: A systematic review and meta-analysis. 
  • Incidental fibromuscular dysplasia in potential renal donors: long-term clinical follow-up. 
  • Incidental living donor nephrectomy: a unique expansion of the donor pool. 
  • Increase in nuclear cell-free DNA is associated with major adverse events in adult and pediatric heart transplant recipients. 
  • Increased kidney transplantation utilizing expanded criteria deceased organ donors with results comparable to standard criteria donor transplant. 
  • Increasing the Availability and Quality of Donor Eyes for Research. 
  • Increasing the United States heart transplant donor pool with donation after circulatory death. 
  • Increasing utilization of human T-cell lymphotropic virus (+) donors in liver transplantation: is it safe? 
  • Indications and techniques for renal, pancreas, and liver transplantation. 
  • Induction therapy with monoclonal antibodies specific for CD80 and CD86 delays the onset of acute renal allograft rejection in non-human primates. 
  • Inflammatory bowel disease after liver transplantation: risk factors for recurrence and de novo disease. 
  • Influence of changes in pretransplant sensitization on patient and graft survival in cadaver renal transplantation. 
  • Influence of donor base deficit status on recipient outcomes in liver transplantation. 
  • Information design to support growth, quality, and equity of the US transplant system. 
  • Innate Immune Activation in High-risk Donor Kidneys: An Opportunity to Intervene? 
  • Innovations in Heart Transplantation: A Review. 
  • Intestinal transplantation at the University of Nebraska Medical Center: 1990 to 2001. 
  • Intestinal transplantation: a single-center experience. 
  • Intravenous digital subtraction angiography in the evaluation of potential renal donors. 
  • Is it time for the United States to engage in heart transplantation using donation after circulatory death? 
  • Is it time to expand the use of cord blood donor transplantation in relapsed ALL? 
  • Is living donor nephrectomy a "23-hr stay" procedure? 
  • Is there a transfusion effect in combined pancreas-kidney transplantation? 
  • Islet xenotransplantation using gal-deficient neonatal donors improves engraftment and function. 
  • Kidney allograft survival of African American and Caucasian American recipients with lupus. 
  • Kidney and pancreas transplantation at Wake Forest University Baptist Medical Center. 
  • Kidney transplantation using living donors. 
  • LFA-1-specific therapy prolongs allograft survival in rhesus macaques. 
  • Late effects in patients with Fanconi anemia following allogeneic hematopoietic stem cell transplantation from alternative donors. 
  • Legal considerations in international eye banking. 
  • Liver and intestine transplantation in the United States, 1997-2006. 
  • Liver transplantation at the University of Wisconsin. 
  • Liver transplantation from a cadaver donor with ethylene-glycol-induced brain death. 
  • Liver transplantation in an adolescent with acute liver failure from acute lymphoblastic leukemia. 
  • Livers from patients with apolipoprotein A-I amyloidosis are not suitable as "domino" donors. 
  • Living related and unrelated donors for kidney transplantation. A 28-year experience. 
  • Living related donor liver transplantation at the University of Nebraska Medical Center (1996). 
  • Living related versus deceased donor liver transplantation for maple syrup urine disease. 
  • Living unrelated kidney donation: an underutilized resource? 
  • Living-related kidney transplant or simultaneous pancreas-kidney for diabetic renal failure? 
  • Living-unrelated renal donor transplantation: the UNOS experience, 1987-1991. United Network for Organ Sharing. 
  • Living-unrelated renal transplantation at the University of Wisconsin. 
  • Long-term outcomes in simultaneous pancreas-kidney transplantation: lessons relearned. 
  • Long-term tolerance of islet allografts in nonhuman primates induced by apoptotic donor leukocytes. 
  • Long-term tolerance to allogeneic thymus transplants in complete DiGeorge anomaly. 
  • Lung Transplantation After Ex Vivo Lung Perfusion Early Outcomes From a US National Registry. 
  • Lung transplantation after ex vivo lung perfusion versus static cold storage: An institutional cost analysis. 
  • Lung transplantation at Duke University Medical Center. 
  • Lung transplantation at Duke University. 
  • Lung transplantation during the COVID-19 pandemic: Safely navigating the new "normal". 
  • Lung transplantation using allografts with more than 8 hours of ischemic time: A single-institution experience. 
  • Lymphocyte reconstitution following non-myeloablative hematopoietic stem cell transplantation follows two patterns depending on age and donor/recipient chimerism. 
  • Lysophosphatidic Acid Induces ECM Production via Activation of the Mechanosensitive YAP/TAZ Transcriptional Pathway in Trabecular Meshwork Cells. 
  • Machine perfusion of donor kidneys may reduce graft rejection. 
  • Malfunction of the liver after transplantation: an analysis of potential risk factors. 
  • Management of the Potential Organ Donor in the ICU: Society of Critical Care Medicine/American College of Chest Physicians/Association of Organ Procurement Organizations Consensus Statement. 
  • Marginal cardiac allografts do not have increased primary graft dysfunction in alternate list transplantation. 
  • Marrow harvesting from normal donors. 
  • Marrow transplantation from HLA-matched unrelated donors for treatment of hematologic malignancies. 
  • Marrow transplantation from unrelated donors for treatment of hematologic malignancies: effect of mismatching for one HLA locus. 
  • Marrow transplants from unrelated donors for treatment of Philadelphia chromosome-positive acute lymphoblastic leukemia. 
  • Maximizing utilization of the donor pool by appropriate classification of hepatitis C antibody-positive donors. 
  • May-Thurner syndrome complicating left-sided donor nephrectomy. 
  • McCarey-Kaufman (MK) organ culture and MK medium-shifted corneas. 
  • Measuring the Impact of Targeting FcRn-Mediated IgG Recycling on Donor-Specific Alloantibodies in a Sensitized NHP Model. 
  • Meeting report of the STAR-Sensitization in Transplantation Assessment of Risk: Naïve Abdominal Transplant Organ subgroup focus on kidney transplantation. 
  • Methods to prevent rejection of homografts in man: a report on living related kidney donor selection by HL-A genotyping. 
  • Microarray analysis of gene expression in human donor sclera. 
  • Mild donor liver steatosis has no impact on hepatitis C virus fibrosis progression following liver transplantation. 
  • Mitigating the Impact of Using Female Donor Hearts in Male Recipients Using BMI Difference. 
  • Mixed leukocyte culture reactivity and graft-versus-host disease in HLA-identical marrow transplantation for leukemia. 
  • Modified MHC restriction of donor-origin T cells in humans with severe combined immunodeficiency transplanted with haploidentical bone marrow stem cells. 
  • Monitoring of kidney and simultaneous pancreas-kidney transplantation rejection by release of donor-specific, soluble HLA class I. 
  • Monoclonal B cell lymphocytosis: clinical and population perspectives. 
  • Morphologic examination of sequential bone marrow biopsies after nonmyeloablative stem cell transplantation complements molecular studies of donor engraftment. 
  • Multivariate analysis of donor-specific versus random transfusion protocols in haploidentical living-related transplants. 
  • Mycobacterium tuberculosis in lung transplant recipients. 
  • National Landscape of Human Immunodeficiency Virus-Positive Deceased Organ Donors in the United States. 
  • National decline in donor heart utilization with regional variability: 1995-2010. 
  • Natural killer cell-enriched donor lymphocyte infusions from A 3-6/6 HLA matched family member following nonmyeloablative allogeneic stem cell transplantation. 
  • Need for improvements in simultaneous heart-kidney allocation: The limitation of pretransplant glomerular filtration rate. 
  • Needle Depth and Big-Bubble Success in Deep Anterior Lamellar Keratoplasty: An Ex Vivo Microscope-Integrated OCT Study. 
  • Neuropathologic studies of the Baltimore Longitudinal Study of Aging (BLSA). 
  • Notes from the field: a cluster of lymphocytic choriomeningitis virus infections transmitted through organ transplantation - Iowa, 2013. 
  • Noteworthy Literature Published in 2018 for Thoracic Organ Transplantation. 
  • Novel Use of Mobile Ex-Vivo Lung Perfusion in Donation After Circulatory Death Lung Transplantation. 
  • Novel delivery method to reduce endothelial injury in descemet stripping automated endothelial keratoplasty. 
  • OPTN/SRTR 2020 Annual Data Report: VCA. 
  • Older donor livers show early severe histological activity, fibrosis, and graft failure after liver transplantation for hepatitis C. 
  • One Size Does Not Fit All--Regional Variation in the Impact of the Share 35 Liver Allocation Policy. 
  • One thousand liver transplants. The lessons learned. 
  • Oocyte donation. The Norfolk Program. 
  • Optimal repair of the composite graft donor wound at the root of the helix. 
  • Organ Donation After Circulatory Death in Greece: Time to Consider. 
  • Organ Transplantation in Greece. 
  • Organ allocation around the world: insights from the ISHLT International Registry for Heart and Lung Transplantation. 
  • Organ donation and the Uniform Anatomical Gift Act. 
  • Organ donation and treatment of the multi-organ donor. 
  • Organ procurement organization (OPO), best practices. 
  • Organ procurement: expenditures and financial incentives. 
  • Outcome in recipients of dual kidney transplants: an analysis of the dual registry patients. 
  • Outcomes of transplantation using organs from a donor infected with Klebsiella pneumoniae carbapenemase (KPC)-producing K. pneumoniae. 
  • Outcomes of transplantation using various hematopoietic cell sources in children with Hurler syndrome after myeloablative conditioning. 
  • Pancreas transplantation at the University of Wisconsin. 
  • Parenteral administration of oral medications in lung transplant recipients: An underrecognized problem. 
  • Partial Heart Transplantation in Adult Cardiac Surgery. 
  • Partial heart transplantation can ameliorate donor organ utilization. 
  • Patient Preferences for Waiting Time and Kidney Quality. 
  • Penetrating keratoplasty in the Singapore National Eye Centre and donor cornea acquisition in the Singapore Eye Bank. 
  • Pennsylvania's voluntary benefits program: evaluating an innovative proposal for increasing organ donation. 
  • Perceived Susceptibility to Chronic Kidney Disease and Hypertension Self-Management among Black and White Live Kidney Donors. 
  • Perceived transparency and fairness of the organ allocation system and willingness to donate organs: a national study. 
  • Perception versus reality?: Virtual crossmatch--how to overcome some of the technical and logistic limitations. 
  • Perspectives on donor lung allocation from both sides of the Atlantic: The United States. 
  • Pharmacological approaches to antibody-mediated rejection-Are we getting closer? 
  • Plerixafor alone for the mobilization and transplantation of HLA-matched sibling donor hematopoietic stem cells. 
  • Porcine islets as an alternative to human islets for transplantation. 
  • Portrayal of organ donation and transplantation on American primetime television. 
  • Potential donor rotational bone grafts using vascular territories in the foot and ankle. 
  • Potential for donation after circulatory death heart transplantation in the United States: Retrospective analysis of a limited UNOS dataset. 
  • Pre-transplant analysis of accommodation in donor pigs. 
  • Precision and linearity targets for validation of an IFNgamma ELISPOT, cytokine flow cytometry, and tetramer assay using CMV peptides. 
  • Predictors of Older Donor Lung Use: Are We Too Good at Saying No? 
  • Predictors of nonuse of donation after circulatory death lung allografts. 
  • Preemptive Tolerogenic Delivery of Donor Antigens for Permanent Allogeneic Islet Graft Protection. 
  • Pregnancy following transfer of ooplasm from cryopreserved-thawed donor oocytes into recipient oocytes. 
  • Preliminary experience with split liver transplantation. 
  • Preloading Trifolded Grafts for Descemet Membrane Endothelial Keratoplasty Affects Scroll Formation. 
  • Preoperative estimation in living related donor transplantation: clinical correlation and donor/recipient ratio. 
  • Preoperative evaluation of potential renal donors using multidetector CT. 
  • Pretransplant exposure to donor HLA-DR antigen in random transfusion units and the development of donor antigen-specific hyporeactivity. 
  • Previous donor pregnancy as a risk factor for acute graft-versus-host disease in patients with aplastic anaemia treated by allogeneic marrow transplantation. 
  • Prisoners on death row should be accepted as organ donors. 
  • Processed electroencephalogram during donation after cardiac death. 
  • Procurement, preservation, and transport of cadaver kidneys. 
  • Prognostic significance of microvascular thrombosis in donor kidney allograft biopsies. 
  • Psychological distress and associated factors among kidney transplant recipients and living kidney donors during COVID-19. 
  • Public attitudes toward incentives for organ donation: a national study of different racial/ethnic and income groups. 
  • Racial and ethnic disparities among donor oocyte banks in the United States. 
  • Rapamycin Interferes With Postdepletion Regulatory T Cell Homeostasis and Enhances DSA Formation Corrected by CTLA4-Ig. 
  • Real-time transcription polymerase chain reaction cycle threshold values as criteria for utilization of incidental COVID-19 positive lung donors. 
  • Reasons why kidneys removed for transplantation are not transplanted in the United States. 
  • Receptor tyrosine kinase MerTK suppresses an allogenic type I IFN response to promote transplant tolerance. 
  • Recommended Treatment for Antibody-mediated Rejection After Kidney Transplantation: The 2019 Expert Consensus From the Transplantion Society Working Group. 
  • Recovery of a human natural antibody against the noncollagenous-1 domain of type IV collagen using humanized models. 
  • Reduced Oxidative Phosphorylation and Increased Glycolysis in Human Glaucoma Lamina Cribrosa Cells. 
  • Reduced antigenicity of formaldehyde-fixed arterial allografts and their potential clinical application. 
  • Reduced-intensity allogeneic transplantation using alemtuzumab from HLA-matched related, unrelated, or haploidentical related donors for patients with hematologic malignancies. 
  • Relationship between donor fraction cell-free DNA and clinical rejection in heart transplantation. 
  • Relationship between provider volume and outcomes for orthotopic liver transplantation. 
  • Reliability of echocardiographic measurements of left ventricular systolic function in potential pediatric heart transplant donors. 
  • Reliability of transthoracic echocardiogram interpretation in potential adult heart transplant donors. 
  • Remote ex vivo lung perfusion at a centralized evaluation facility. 
  • Renal Transplantation with grafts affected by tumors: learning from a 'near miss' case. 
  • Renal cell carcinoma suspected at time of organ donation 2008-2016: A report of the OPTN ad hoc Disease Transmission Advisory Committee Registry. 
  • Renal magnetic resonance angiography in the preoperative detection of supernumerary renal arteries in potential kidney donors. 
  • Renal transplantation between HL-A haploidentical donor-recipient pairs: functional and morphological evaluation. 
  • Renal transplantation between histocompatible donor-recipient pairs. 
  • Repeatability of central corneal thickness measurements of donor corneas in preservation chamber using Fourier-domain anterior segment optical coherence tomography. 
  • Reply from authors: Heart donor brain death duration-external validation from across the pond. 
  • Reply from the authors: We do not know what we do not know-Mechanism of donor brain death and transplant recipient outcomes. 
  • Reply: Is hepatocyte necrosis a good marker of donor liver viability during machine perfusion? 
  • Reply: To PMID 22632483. 
  • Report From the American Society of Transplantation Conference on Donor Heart Selection in Adult Cardiac Transplantation in the United States. 
  • Repugnance Management and Transactions in the Body. 
  • Rescue thrombolysis: resolution of intraglomerular thrombi after donation after circulatory death. 
  • Response and toxicity of donor lymphocyte infusions following T-cell depleted non-myeloablative allogeneic hematopoietic SCT from 3-6/6 HLA matched donors. 
  • Response to the Comment on "Improvement in Liver Transplant Outcomes From Older Donors: A US National Analysis". 
  • Review of the use of hepatitis B core antibody-positive kidney donors. 
  • Right ventricular dysfunction after cardiac transplantation: primarily related to status of donor heart. 
  • Risk factor analysis of outcomes after unrelated cord blood transplantation in patients with hurler syndrome. 
  • Risk factors for acute GVHD and survival after hematopoietic cell transplantation. 
  • Risk factors for mortality in lung transplant recipients aged ≥65 years: A retrospective cohort study of 5,815 patients in the scientific registry of transplant recipients. 
  • Risk factors for primary dysfunction after liver transplantation--a multivariate analysis. 
  • Risk for transmission of Naegleria fowleri from solid organ transplantation. 
  • Role of coronary artery calcium score in identifying occult coronary artery disease in patients evaluated for deceased-donor liver transplant - a preliminary report. 
  • SARS-CoV-2 Antibody Serology Testing in a 3-Month-Old Organ Donor: A Case Report and Review of Available Literature. 
  • SRTR center-specific reporting tools: Posttransplant outcomes. 
  • Screening for previous refractive surgery in eye bank corneas by using optical coherence tomography. 
  • Seek and you will find: antibody and the liver. 
  • Selection of donors for kidney transplantation. 
  • Sensitization in Transplantation: Assessment of Risk (STAR) 2017 Working Group Meeting Report. 
  • Significance of complement split product C4d in ABO-compatible liver allograft: diagnosing utility in acute antibody mediated rejection. 
  • Simultaneous pancreas-kidney (SPK) transplantation from controlled non-heart-beating donors (NHBDs). 
  • Simultaneous pancreas-kidney transplantation from donation after cardiac death: successful long-term outcomes. 
  • Single cell transcriptomics of mouse kidney transplants reveals a myeloid cell pathway for transplant rejection. 
  • Single-cell RNA-seq of out-of-thaw mesenchymal stromal cells shows tissue-of-origin differences and inter-donor cell-cycle variations. 
  • Single-center experience with renal transplantation in patients with Wegener's granulomatosis. 
  • Single-lung transplantation in the United States: what happens to the other lung? 
  • Solid organ transplant donors with central nervous system infection. 
  • Solid-organ transplantation in older adults: current status and future research. 
  • Spiral (helical) CT of the renal vasculature. 
  • Stable mixed hematopoietic chimerism after bone marrow transplantation for sickle cell anemia. 
  • Stem cell source and outcome after hematopoietic stem cell transplantation (HSCT) in children and adolescents with acute leukemia. 
  • Structural remodeling of cardiac myocytes in patients with ischemic cardiomyopathy. 
  • Successful Implementation of a Program for Increasing Donor Eyes for Research: The Duke-Miracles In Sight Program. 
  • Successful allogeneic engraftment of mismatched unrelated cord blood following a nonmyeloablative preparative regimen. 
  • Successful combined liver/kidney transplantation from a donor with Pompe disease. 
  • Successful emergency transplantation of a liver allograft from a donor maintained on extracorporeal membrane oxygenation. 
  • Successful extrarenal transplantation from non-heart-beating donors. 
  • Successful haploidentical donor hematopoietic stem cell transplant and restoration of STAT3 function in an adolescent with autosomal dominant hyper-IgE syndrome. 
  • Surgical technique in transplantation: how much does it matter? 
  • Survival Benefit of Lung Transplantation in the Modern Era of Lung Allocation. 
  • Symptomatic pulmonary allograft Kaposi's sarcoma in two lung transplant recipients. 
  • Systemic Complement Activation in Donation After Brain Death Versus Donation After Circulatory Death Organ Donors. 
  • Techniques, Outcomes, and Complications of Preloaded, Trifolded Descemet Membrane Endothelial Keratoplasty Using the DMEK EndoGlide. 
  • Tempering allorecognition to induce transplant tolerance with chemically modified apoptotic donor cells. 
  • Temporal Changes in Left Ventricular Systolic Function and Use of Echocardiography in Adult Heart Donors. 
  • Ten years of donor-derived disease: A report of the disease transmission advisory committee. 
  • Ten-year experience with extended criteria cardiac transplantation. 
  • Textbook surgical outcome in lung transplantation: Analysis of a US national registry. 
  • The "PHS Increased Risk" Label Is Associated With Nonutilization of Hundreds of Organs per Year. 
  • The Clinical Impact of Non-HLA Antibodies in Solid Organ Transplantation. 
  • The Future of heart procurement with donation after circulatory death: Current practice and opportunities for advancement. 
  • The International Society of Heart and Lung Transplantation Guidelines for the care of heart transplant recipients. 
  • The OPTN Deceased Donor Potential Study: Implications for Policy and Practice. 
  • The Volume-outcome Relationship in Deceased Donor Kidney Transplantation and Implications for Regionalization. 
  • The allocation of cadaver kidneys for transplantation in the United States: consensus and controversy. ASN Transplant Advisory Group. American Society of Nephrology. 
  • The association of donor age and survival is independent of ischemic time following deceased donor lung transplantation. 
  • The association with organ procurement techniques and early cardiac transplant outcomes using cardiac MRI. 
  • The best transplant strategy? It depends. 
  • The combination of donor and recipient age is critical in determining host immunoresponsiveness and renal transplant outcome. 
  • The effect of prior pneumonectomy or lobectomy on subsequent lung transplantation. 
  • The effect of the Statewide Sharing variance on geographic disparity in kidney transplantation in the United States. 
  • The extent and predictors of waiting time geographic disparity in kidney transplantation in the United States. 
  • The heart transplant allocation change attenuates but does not eliminate blood group O waitlist outcome disadvantage. 
  • The histology of graft adhesion in descemet stripping with endothelial keratoplasty. 
  • The impact of donor variables on the outcome of orthotopic liver transplantation for hepatitis C. 
  • The impact of donor-recipient sex matching on survival after orthotopic heart transplantation: analysis of 18 000 transplants in the modern era. 
  • The impact of human leukocyte antigen donor and recipient serotyping and matching on liver transplant graft failure in primary sclerosing cholangitis, autoimmune hepatitis, and primary biliary cholangitis. 
  • The impact of slow graft function on graft outcome is comparable to delayed graft function in deceased donor kidney transplantation. 
  • The incidence of donor-site morbidity after transverse cervical artery vascularized lymph node transfers: the need for a lymphatic surgery national registry. 
  • The influence of stem cell source on transplant outcomes for pediatric patients with acute myeloid leukemia. 
  • The new OPTN kidney allocation policy: potential for inequitable access among highly sensitized patients. 
  • The pandemic provides a pathway: What we know and what we need to know about using COVID positive donors. 
  • The predictive value of donor liver biopsies on the development of primary nonfunction after orthotopic liver transplantation. 
  • The probability of HLA-C matching between patient and unrelated donor at the molecular level: estimations based on the linkage disequilibrium between DNA typed HLA-B and HLA-C alleles. 
  • The rehabilitation of renal allograft recipients. 
  • The relationship between plasma lipid peroxidation products and primary graft dysfunction after lung transplantation is modified by donor smoking and reperfusion hyperoxia. 
  • The role of donor-specific HLA alloantibodies in liver transplantation. 
  • The role of the prostaglandin EP4 receptor in the regulation of human outflow facility. 
  • The role of therapeutic apheresis in high immunologic risk renal transplantation: a review of current trends. 
  • The spectrum of kidney disease in patients with AIDS in the era of antiretroviral therapy. 
  • The trade-off of using positive-smoking donor lungs. 
  • The use of bilateral adult renal allografts - a method to optimize function from donor kidneys with suboptimal nephron mass. 
  • The use of spiral computed tomography in the evaluation of living donors for kidney transplantation. 
  • Thermal study of longitudinal and torsional ultrasound phacoemulsification: tracking the temperature of the corneal surface, incision, and handpiece. 
  • Third-party reproduction in the Internet Age: the new, patient-centered landscape. 
  • Thoracic organ transplantation at Papworth Hospital. 
  • Thrombocytopenia in allogeneic peripheral blood stem cell collections. 
  • Transcriptional responses define dysregulated immune activation in Hepatitis C (HCV)-naïve recipients of HCV-infected donor kidneys. 
  • Transmission of cancer with cadaveric donor organs. 
  • Transmission of latent cytomegalovirus in a murine kidney tissue transplantation model. 
  • Transplant Center Variability in Organ Offer Acceptance and Mortality Among US Patients on the Heart Transplant Waitlist. 
  • Transplant size mismatch in restrictive lung disease. 
  • Transplantation traffic--geography as destiny for transplant candidates. 
  • Transplantation-mediated alloimmune thrombocytopenia: Guidelines for utilization of thrombocytopenic donors. 
  • Transplanting the highly sensitized patient: trials and tribulations. 
  • Transplanting thoracic COVID-19 positive donors: An institutional protocol and report of the first 14 cases. 
  • Trends and Outcomes of Cardiac Transplantation in the Lowest Urgency Candidates. 
  • Trends and outcomes of cardiac transplantation from donors dying of drug intoxication. 
  • Trends in cardiovascular medicine: Update on cardiac transplantation. 
  • Umbilical cord blood transplantation in adults using myeloablative and nonmyeloablative preparative regimens. 
  • Understanding disparities in donor behavior: race and gender differences in willingness to donate blood and cadaveric organs. 
  • Underutilization of pancreas donors. 
  • Unrecognized pretransplant and donor‐derived cryptococcal disease in organ transplant recipients. 
  • Unrelated and HLA-nonidentical related donor marrow transplantation for thalassemia and leukemia. A combined report from the Seattle Marrow Transplant Team and the International Bone Marrow Transplant Registry. 
  • Unrelated donor marrow transplantation in children. 
  • Unrelated donor umbilical cord blood transplantation for inherited metabolic disorders in 159 pediatric patients from a single center: influence of cellular composition of the graft on transplantation outcomes. 
  • Unrelated donor umbilical cord blood transplantation in pediatric myelodysplastic syndrome: a single-center experience. 
  • Update in lung transplantation 2013. 
  • Update on preservation of liver grafts. 
  • Use of Temporary Mechanical Circulatory Support for Management of Cardiogenic Shock Before and After the United Network for Organ Sharing Donor Heart Allocation System Changes. 
  • Use of donor serum to prevent passive transfer of hyperacute rejection. 
  • Use of human gametes obtained from anonymous donors for the production of human embryonic stem cell lines. 
  • Use of lung allografts from brain-dead donors after cardiopulmonary arrest and resuscitation. 
  • Use of renal allografts from donors positive for hepatitis B core antibody confers minimal risk for subsequent development of clinical hepatitis B virus disease. 
  • Utilization of hepatitis C virus-infected organ donors in cardiothoracic transplantation: An ISHLT expert consensus statement. 
  • Utilization of pediatric donors for pancreas transplantation. 
  • Utilization of the older donor for renal transplantation. 
  • V2-Directed Vaccine-like Antibodies from HIV-1 Infection Identify an Additional K169-Binding Light Chain Motif with Broad ADCC Activity. 
  • Variability in donor organ offer acceptance and lung transplantation survival. 
  • Variable HLA expression on deceased donor lymphocytes: Not all crossmatches are created equal. 
  • Vascular communications between donor and recipient tissues after successful full face transplantation. 
  • Vascularized composite allotransplantation in the United States: A descriptive analysis of the Organ Procurement and Transplantation Network Data. 
  • What's in a Name? The Diminishing Value of Quality Designations for Donor Lungs. 
  • Whole body donation for medical science: a population-based study. 
  • Worldwide legal requirements for obtaining corneas: 1990. 
  • iPSC-Derived Endothelial Cells Affect Vascular Function in a Tissue-Engineered Blood Vessel Model of Hutchinson-Gilford Progeria Syndrome. 
• 

  Keywords of People

  • McCall, Shannon Jones, Associate Professor of Pathology, Pathology
  • Milano, Carmelo Alessio, Joseph W. and Dorothy W. Beard Distinguished Professor of Experimental Surgery, Surgery, Cardiovascular and Thoracic Surgery